Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

CHD5 is a tumor suppressor at human 1p36.

Bagchi A, Papazoglu C, Wu Y, Capurso D, Brodt M, Francis D, Bredel M, Vogel H, Mills AA.

Cell. 2007 Feb 9;128(3):459-75.

2.

Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer.

Wu X, Zhu Z, Li W, Fu X, Su D, Fu L, Zhang Z, Luo A, Sun X, Fu L, Dong JT.

Breast Cancer Res. 2012 May 8;14(3):R73.

3.

CHD5 is down-regulated through promoter hypermethylation in gastric cancer.

Wang X, Lau KK, So LK, Lam YW.

J Biomed Sci. 2009 Oct 19;16:95. doi: 10.1186/1423-0127-16-95.

4.

MicroRNA-211 expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor suppressor CHD5.

Cai C, Ashktorab H, Pang X, Zhao Y, Sha W, Liu Y, Gu X.

PLoS One. 2012;7(1):e29750. doi: 10.1371/journal.pone.0029750. Epub 2012 Jan 3.

5.

CHD5, a tumor suppressor that is epigenetically silenced in lung cancer.

Zhao R, Yan Q, Lv J, Huang H, Zheng W, Zhang B, Ma W.

Lung Cancer. 2012 Jun;76(3):324-31. doi: 10.1016/j.lungcan.2011.11.019. Epub 2011 Dec 18.

PMID:
22186629
6.

The quest for the 1p36 tumor suppressor.

Bagchi A, Mills AA.

Cancer Res. 2008 Apr 15;68(8):2551-6. doi: 10.1158/0008-5472.CAN-07-2095. Review.

7.

CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.

Fujita T, Igarashi J, Okawa ER, Gotoh T, Manne J, Kolla V, Kim J, Zhao H, Pawel BR, London WB, Maris JM, White PS, Brodeur GM.

J Natl Cancer Inst. 2008 Jul 2;100(13):940-9. doi: 10.1093/jnci/djn176. Epub 2008 Jun 24.

9.

JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5.

Mallette FA, Richard S.

Cell Rep. 2012 Nov 29;2(5):1233-43. doi: 10.1016/j.celrep.2012.09.033. Epub 2012 Nov 15.

10.

Role of CHD5 in human cancers: 10 years later.

Kolla V, Zhuang T, Higashi M, Naraparaju K, Brodeur GM.

Cancer Res. 2014 Feb 1;74(3):652-8. doi: 10.1158/0008-5472.CAN-13-3056. Epub 2014 Jan 13. Review.

11.

1p36 tumor suppression--a matter of dosage?

Henrich KO, Schwab M, Westermann F.

Cancer Res. 2012 Dec 1;72(23):6079-88. doi: 10.1158/0008-5472.CAN-12-2230. Epub 2012 Nov 20. Review.

12.

Disruption of the Cockayne syndrome B gene impairs spontaneous tumorigenesis in cancer-predisposed Ink4a/ARF knockout mice.

Lu Y, Lian H, Sharma P, Schreiber-Agus N, Russell RG, Chin L, van der Horst GT, Bregman DB.

Mol Cell Biol. 2001 Mar;21(5):1810-8.

13.

Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice.

You MJ, Castrillon DH, Bastian BC, O'Hagan RC, Bosenberg MW, Parsons R, Chin L, DePinho RA.

Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1455-60. Epub 2002 Jan 29.

14.

p53-Dependent and -independent functions of the Arf tumor suppressor.

Sherr CJ, Bertwistle D, DEN Besten W, Kuo ML, Sugimoto M, Tago K, Williams RT, Zindy F, Roussel MF.

Cold Spring Harb Symp Quant Biol. 2005;70:129-37. Review.

PMID:
16869746
15.

Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.

Boström J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G.

Am J Pathol. 2001 Aug;159(2):661-9.

16.

Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.

Sonoda Y, Yoshimoto T, Sekiya T.

Oncogene. 1995 Nov 16;11(10):2145-9.

PMID:
7478535
17.

CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system.

Thompson PM, Gotoh T, Kok M, White PS, Brodeur GM.

Oncogene. 2003 Feb 20;22(7):1002-11.

PMID:
12592387
18.

The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.

Sharpless NE, Ramsey MR, Balasubramanian P, Castrillon DH, DePinho RA.

Oncogene. 2004 Jan 15;23(2):379-85.

PMID:
14724566
19.
20.

Preliminary evidence for involvement of the tumour suppressor gene CHD5 in a family with cutaneous melanoma.

Lang J, Tobias ES, Mackie R.

Br J Dermatol. 2011 May;164(5):1010-6. doi: 10.1111/j.1365-2133.2011.10223.x.

PMID:
21250965

Supplemental Content

Support Center